OSTEOARTHRITIS
Prolonged use of corticosteroid injections for knee osteoarthritis reduces cartilage volume
JAMA. 2017 May 16;317(19):1967-1975140 patients with symptomatic knee osteoarthritis (Kellgren-Lawrence grade II-III) and ultrasonographic evidence of synovitis were included in this trial to determine the effects of prolonged corticosteroid use on cartilage loss and pain. Patients were randomized to injections of triamcinolone acetonide or saline every 12 weeks for a period of two years. The outcomes assessed included cartilage loss and damage (MRI), pain, function, and adverse events. The results of this trial indicated that corticosteroid treatment led to a greater loss of cartilage at 2 years compared to the saline group, with no significant differences in pain outcomes between groups.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
